Denali Capital Acquisition Corp.
Definitive Agreement
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $75M
- Focus
- Technology, Consumer, Hospitality
- SEC Filings
- 1913577
- Public Embarc Page
- https://embarc.com/capital/spac/1913577/DECA/denali-capital-acquisition
SPAC Leadership
Information on the SPAC leadership.
- Jiandong Xu
- Chief Executive Officer and DirectorLei Huang
- Independent DirectorHuifeng Chang
- Independent DirectorJim Mao
- Independent DirectorKevin Vassily
Target Information
Information on the SPAC target for merger.
- Company
- Longevity Biomedical, Inc